WCLC 2025 - Posters & ePosters-P3.12.34 Real-World Study in Patients With ALK+ Metastatic Non-Small Cell Lung Cancer (mNSCLC) Treated With First-Line (1L) Lorlatinib

P3.12.34 Real-World Study in Patients With ALK+ Metastatic Non-Small Cell Lung Cancer (mNSCLC) Treated With First-Line (1L) Lorlatinib

Asset Subtitle

Shirish Gadgeel

Meta Tag

Speaker Shirish Gadgeel

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy